Cited by 32Clinical Laboratory Practices and Quality ControlDiabetes Management and ResearchScientific Measurement and Uncertainty Evaluation

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Hemoglobin A1c Point-of-Care Assays; A New World with a Lot of Consequences!

Open access
Lenters-Westra, Erna, Slingerland, Robbert J.·2009·Journal of Diabetes Science and Technology

Abstract

Background Point-of-care instruments for the measurement of hemoglobin A1c (HbA1c) may improve the glycemic control of people with diabetes by providing a rapid result if the performance of the instruments used is acceptable. A 0.5% HbA1c difference between successive results is considered a clinically relevant change. With this in mind, the In2it from Bio-Rad and the DCA Vantage from Siemens were evaluated according to Clinical and Laboratory Standards Institute (CLSI) protocols. Methods The CLSI protocols EP-5 and EP-9 were applied to investigate precision, accuracy, and bias. The bias was compared with three certified secondary reference measurement procedures. Differences between capillary and venous blood were investigated by an end-user group consisting of nurse practitioners at a diabetes care center. Results At HbA1c levels of 5.1 and 11.2%, total coefficients of variation (CV) for the In2it were 4.9 and 3.3%, respectively, and for the DCA Vantage were 1.7 to 1.8% and 3.7 to 5.5% depending on the lot number of the cartridges. Method comparisons showed significant lot number-dependent results for the In2it and the DCA Vantage compared with the three reference methods. No overall difference was observed between capillary and venous blood for both methods. Conclusion Performance results of the In2it and the DCA Vantage showed variable and lot number-dependent results. To maintain the interlaboratory CV of 5% for HbA1c, the Clinical Laboratory Improvement Amendments rules…

Overview

Integrity signals

Registry

Crossref · 10.1177/193229680900300303

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. Hawkins RC, 2003, Singapore Med J., 44, 8
  2. Clinical and Laboratory Standards Institute, 1998, Preliminary evaluation of clinical chemistry methods; approved guideline
  3. Clinical and Laboratory Standards Institute, 1992, Evaluation of precision performance of clinical chemistry devices; approved guideline
  4. Clinical and Laboratory Standards Institute, 1995, Method comparison and bias estimation using patient samples; approved guideline
  5. Rhoads DG, EP Evaluator Release 8
  6. Guercci B, 1997, Diabetes Metab., 23, 195
  7. Fonfrède M, 1998, Diabetes Metab., 24, 66
  8. College of American Pathologists, 2008, Glycohemoglobin Survey 2008, set GH2-B.

Cited by

Sorted by citations

Metadata

Authors
Lenters-Westra, E., & Slingerland, R. J.
Affiliations
  • Department of Clinical Chemistry, Isala klinieken, Zwolle, The Netherlands
  • Isala (NL)
Venue
Journal of Diabetes Science and Technology
Published
2009-05
Volume
3
Issue
3
Pages
418-423
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2000610385
Cited by
31
References
11
Citations by year
2026: 2 · 2024: 1 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 3
Type
conference abstract
Language
en
Open access
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Physical Sciences › Physics and Astronomy › Instrumentation › Scientific Measurement and Uncertainty Evaluation
Keywords
HbA1c, point-of-care testing, precision and accuracy, external quality assessment, Clinical Laboratory Improvement Amendments, nurse practitioners
MeSH terms
Blood Glucose, Capillaries, Clinical Protocols, Glycated Hemoglobin, Humans, Quality Control, Veins, Reproducibility of Results, Point-of-Care Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review